FDA approves miniature capsule formulation of omeprazole magnesium for heartburn

The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules for over-the-counter treatment of frequent heartburn., according to a company press release.
Approximately 70% smaller than the standard tablet version of omeprazole currently available, the “first-to-market” miniature capsule is intended to “provide a differentiated and preferred product offering for consumers,” noted the press release.
“This approval illustrates Perrigo’s research and development and regulatory expertise and our continued

The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules for over-the-counter treatment of frequent heartburn., according to a company press release.
Approximately 70% smaller than the standard tablet version of omeprazole currently available, the “first-to-market” miniature capsule is intended to “provide a differentiated and preferred product offering for consumers,” noted the press release.
“This approval illustrates Perrigo’s research and development and regulatory expertise and our continued